Your browser doesn't support javascript.
loading
Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy.
Ignatiadis, Michail; Van den Eynden, Gert; Roberto, Salgado; Fornili, Marco; Bareche, Yacine; Desmedt, Christine; Rothé, Françoise; Maetens, Marion; Venet, David; Holgado, Esther; McNally, Virginia; Kiermaier, Astrid; Savage, Heidi M; Wilson, Timothy R; Cortes, Javier; Schneeweiss, Andreas; Willard-Gallo, Karen; Biganzoli, Elia; Sotiriou, Christos.
Afiliação
  • Ignatiadis M; Department of Medical Oncology, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Van den Eynden G; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Roberto S; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Fornili M; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Bareche Y; Department of Pathology, GZA, Antwerp, Belgium.
  • Desmedt C; University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy.
  • Rothé F; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Maetens M; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Venet D; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Holgado E; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • McNally V; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Kiermaier A; Ramon y Cajal University Hospital, Madrid, Spain.
  • Savage HM; Oncology Biomarker Development, Genentech Inc., Basel, Switzerland.
  • Wilson TR; Oncology Biomarker Development, Genentech Inc., Basel, Switzerland.
  • Cortes J; Oncology Biomarker Development, Genentech Inc., South San Francisco, CA.
  • Schneeweiss A; Oncology Biomarker Development, Genentech Inc., South San Francisco, CA.
  • Willard-Gallo K; Ramon y Cajal University Hospital, Madrid, Spain.
  • Biganzoli E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Sotiriou C; Divison of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Heidelberg, Germany.
J Natl Cancer Inst ; 111(1): 69-77, 2019 01 01.
Article em En | MEDLINE | ID: mdl-29788230
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2019 Tipo de documento: Article